Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.36107096 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.33669365 |
3 | negative regulation of cell killing (GO:0031342) | 6.33669365 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.21733379 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.93055899 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.77846316 |
7 | modulation by symbiont of host defense response (GO:0052031) | 5.77846316 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.77846316 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.77846316 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.77846316 |
11 | modulation by symbiont of host immune response (GO:0052553) | 5.77846316 |
12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.73859582 |
13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.69838729 |
14 | neutrophil activation involved in immune response (GO:0002283) | 5.43650852 |
15 | macrophage activation involved in immune response (GO:0002281) | 5.34739704 |
16 | detection of other organism (GO:0098543) | 4.96982333 |
17 | negative regulation of interleukin-12 production (GO:0032695) | 4.71233582 |
18 | detection of bacterium (GO:0016045) | 4.69434827 |
19 | response to peptidoglycan (GO:0032494) | 4.65263095 |
20 | detection of molecule of bacterial origin (GO:0032490) | 4.64785997 |
21 | microglial cell activation (GO:0001774) | 4.51022427 |
22 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50371534 |
23 | detection of external biotic stimulus (GO:0098581) | 4.50049989 |
24 | immunoglobulin mediated immune response (GO:0016064) | 4.44404897 |
25 | cellular extravasation (GO:0045123) | 4.40528426 |
26 | neutrophil activation (GO:0042119) | 4.13129961 |
27 | regulation of gamma-delta T cell activation (GO:0046643) | 4.10820103 |
28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.07312777 |
29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.06817240 |
30 | leukocyte aggregation (GO:0070486) | 4.02268086 |
31 | respiratory burst (GO:0045730) | 4.01086078 |
32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.98291885 |
33 | macrophage activation (GO:0042116) | 3.96020888 |
34 | detection of biotic stimulus (GO:0009595) | 3.94456125 |
35 | response to host immune response (GO:0052572) | 3.88964430 |
36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.88964430 |
37 | granulocyte activation (GO:0036230) | 3.88914142 |
38 | myeloid cell activation involved in immune response (GO:0002275) | 3.87631497 |
39 | response to interleukin-15 (GO:0070672) | 3.77790280 |
40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.73502767 |
41 | regulation of mast cell degranulation (GO:0043304) | 3.72200819 |
42 | type I interferon signaling pathway (GO:0060337) | 3.70675538 |
43 | cellular response to type I interferon (GO:0071357) | 3.70675538 |
44 | positive regulation of mast cell activation (GO:0033005) | 3.69654817 |
45 | response to type I interferon (GO:0034340) | 3.67198725 |
46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.65665318 |
47 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.64080405 |
48 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.62520643 |
49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.59655292 |
50 | cellular response to interleukin-15 (GO:0071350) | 3.58920835 |
51 | regulation of T cell tolerance induction (GO:0002664) | 3.57203826 |
52 | response to host defenses (GO:0052200) | 3.53934165 |
53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.53934165 |
54 | response to host (GO:0075136) | 3.53934165 |
55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.50829297 |
56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50204203 |
57 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.47243130 |
58 | regulation of tolerance induction (GO:0002643) | 3.45309753 |
59 | B cell mediated immunity (GO:0019724) | 3.44624929 |
60 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.42483944 |
61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.37781853 |
62 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.35563965 |
63 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.30019862 |
64 | positive regulation of mast cell degranulation (GO:0043306) | 3.30019862 |
65 | regulation of leukocyte degranulation (GO:0043300) | 3.29123085 |
66 | regulation of mast cell activation (GO:0033003) | 3.26942069 |
67 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.23780955 |
68 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.18743173 |
69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.15943405 |
70 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.15943405 |
71 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15603973 |
72 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.15088271 |
73 | T cell migration (GO:0072678) | 3.13804158 |
74 | neutrophil mediated immunity (GO:0002446) | 3.13259557 |
75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.10984603 |
76 | regulation of antigen processing and presentation (GO:0002577) | 3.10556017 |
77 | B cell receptor signaling pathway (GO:0050853) | 3.05211242 |
78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05072676 |
79 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03282771 |
80 | defense response to protozoan (GO:0042832) | 3.02938386 |
81 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.02604927 |
82 | positive regulation of B cell differentiation (GO:0045579) | 3.02423689 |
83 | regulation of B cell differentiation (GO:0045577) | 3.02108105 |
84 | positive thymic T cell selection (GO:0045059) | 3.01094944 |
85 | negative regulation of innate immune response (GO:0045824) | 3.00335765 |
86 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.99787309 |
87 | myeloid leukocyte mediated immunity (GO:0002444) | 2.98838030 |
88 | activated T cell proliferation (GO:0050798) | 2.97664064 |
89 | dendritic cell chemotaxis (GO:0002407) | 2.96269995 |
90 | leukocyte degranulation (GO:0043299) | 2.95441537 |
91 | myeloid leukocyte activation (GO:0002274) | 2.95032959 |
92 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94727571 |
93 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94369730 |
94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92964168 |
95 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91915100 |
96 | response to muramyl dipeptide (GO:0032495) | 2.88844403 |
97 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.88102109 |
98 | dendritic cell migration (GO:0036336) | 2.88023562 |
99 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87004071 |
100 | positive regulation of interferon-alpha production (GO:0032727) | 2.86809408 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.05723984 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.05217679 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.69372053 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.75768319 |
5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60236866 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.54109014 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.50245347 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.40808743 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.10185512 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92589162 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.87911630 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71713510 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67563449 |
14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.64468328 |
15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.63281076 |
16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.60116716 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.58822414 |
18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.48340311 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.37608444 |
20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36789423 |
21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.34032279 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26897781 |
23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22274818 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.13797248 |
25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12117607 |
26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11636597 |
27 | * MYB_26560356_Chip-Seq_TH2_Human | 2.11327888 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.06473185 |
29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05622981 |
30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03833922 |
31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03112013 |
32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99044211 |
33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.94298514 |
34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86408187 |
35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83822964 |
36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81148692 |
37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79233039 |
38 | MYB_26560356_Chip-Seq_TH1_Human | 1.78380936 |
39 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71667626 |
40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63802845 |
41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62481160 |
42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61541902 |
43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60202015 |
44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54850875 |
45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53547998 |
46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52661424 |
47 | MAF_26560356_Chip-Seq_TH2_Human | 1.52560747 |
48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52130147 |
49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50870063 |
50 | MYC_22102868_ChIP-Seq_BL_Human | 1.47939306 |
51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45902818 |
52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39258566 |
53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38145650 |
54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38093142 |
55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37510976 |
56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31758758 |
57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30422218 |
58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30260994 |
59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30258693 |
60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30118232 |
61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29153346 |
62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29076979 |
63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25626173 |
64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25506865 |
65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23949586 |
66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23869164 |
67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23423743 |
68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23006259 |
69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21222807 |
70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19147057 |
71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.18954029 |
72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18635641 |
73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16080393 |
74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15790826 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14305692 |
76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14138158 |
77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10298042 |
78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09657237 |
79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05489728 |
80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05468260 |
81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01527949 |
82 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99365537 |
83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98948215 |
84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97040321 |
85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94477898 |
86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93704286 |
87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93609643 |
88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92532532 |
89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89300998 |
90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88915308 |
91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88644037 |
92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86818251 |
93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79819575 |
94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77334010 |
95 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76845190 |
96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.76741881 |
97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76199112 |
98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74588474 |
99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.74131451 |
100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73450207 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.88290418 |
2 | MP0001835_abnormal_antigen_presentation | 4.08630958 |
3 | MP0003436_decreased_susceptibility_to | 4.04957598 |
4 | MP0003303_peritoneal_inflammation | 3.53359159 |
5 | MP0005671_abnormal_response_to | 3.45726527 |
6 | MP0006082_CNS_inflammation | 3.40957134 |
7 | MP0002419_abnormal_innate_immunity | 3.24279835 |
8 | MP0009785_altered_susceptibility_to | 3.12407642 |
9 | MP0005025_abnormal_response_to | 3.00690939 |
10 | MP0001790_abnormal_immune_system | 2.90477371 |
11 | MP0005387_immune_system_phenotype | 2.90477371 |
12 | MP0005000_abnormal_immune_tolerance | 2.89489078 |
13 | MP0000685_abnormal_immune_system | 2.84991954 |
14 | MP0001800_abnormal_humoral_immune | 2.83480601 |
15 | MP0002723_abnormal_immune_serum | 2.60391416 |
16 | MP0002148_abnormal_hypersensitivity_rea | 2.56981311 |
17 | MP0002452_abnormal_antigen_presenting | 2.54766484 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.51081253 |
19 | MP0002420_abnormal_adaptive_immunity | 2.46698641 |
20 | MP0001819_abnormal_immune_cell | 2.44444753 |
21 | MP0003300_gastrointestinal_ulcer | 2.38363918 |
22 | MP0001533_abnormal_skeleton_physiology | 2.18796078 |
23 | MP0005464_abnormal_platelet_physiology | 2.07999529 |
24 | MP0002405_respiratory_system_inflammati | 1.96769768 |
25 | MP0008260_abnormal_autophagy | 1.93059131 |
26 | MP0003172_abnormal_lysosome_physiology | 1.91663294 |
27 | MP0001845_abnormal_inflammatory_respons | 1.84324554 |
28 | MP0003763_abnormal_thymus_physiology | 1.82395017 |
29 | MP0000716_abnormal_immune_system | 1.78966858 |
30 | MP0010155_abnormal_intestine_physiology | 1.75577765 |
31 | MP0005058_abnormal_lysosome_morphology | 1.72066298 |
32 | MP0003690_abnormal_glial_cell | 1.71604298 |
33 | MP0003828_pulmonary_edema | 1.71516179 |
34 | MP0002398_abnormal_bone_marrow | 1.69727315 |
35 | MP0009764_decreased_sensitivity_to | 1.66506889 |
36 | MP0009333_abnormal_splenocyte_physiolog | 1.63913377 |
37 | MP0008469_abnormal_protein_level | 1.58541348 |
38 | MP0004883_abnormal_blood_vessel | 1.57677016 |
39 | MP0004947_skin_inflammation | 1.57516086 |
40 | MP0003075_altered_response_to | 1.54545148 |
41 | MP0000858_altered_metastatic_potential | 1.51425273 |
42 | MP0009278_abnormal_bone_marrow | 1.50497670 |
43 | MP0002277_abnormal_respiratory_mucosa | 1.49152942 |
44 | MP0003183_abnormal_peptide_metabolism | 1.48605281 |
45 | MP0002998_abnormal_bone_remodeling | 1.46968581 |
46 | MP0000689_abnormal_spleen_morphology | 1.45607750 |
47 | MP0002132_abnormal_respiratory_system | 1.42355496 |
48 | MP0003866_abnormal_defecation | 1.40847502 |
49 | MP0000343_altered_response_to | 1.40811267 |
50 | MP0005310_abnormal_salivary_gland | 1.40619426 |
51 | MP0000604_amyloidosis | 1.40451383 |
52 | MP0002722_abnormal_immune_system | 1.40363225 |
53 | MP0002429_abnormal_blood_cell | 1.37495952 |
54 | MP0000465_gastrointestinal_hemorrhage | 1.36263852 |
55 | MP0004510_myositis | 1.30581920 |
56 | MP0005451_abnormal_body_composition | 1.28675472 |
57 | MP0005164_abnormal_response_to | 1.25776722 |
58 | MP0009840_abnormal_foam_cell | 1.24761304 |
59 | MP0003448_altered_tumor_morphology | 1.22606506 |
60 | MP0001851_eye_inflammation | 1.20696554 |
61 | MP0005166_decreased_susceptibility_to | 1.20478455 |
62 | MP0000703_abnormal_thymus_morphology | 1.15496026 |
63 | MP0005397_hematopoietic_system_phenotyp | 1.13520660 |
64 | MP0001545_abnormal_hematopoietic_system | 1.13520660 |
65 | MP0001853_heart_inflammation | 1.06326691 |
66 | MP0004381_abnormal_hair_follicle | 1.02892237 |
67 | MP0009763_increased_sensitivity_to | 0.97944397 |
68 | MP0002396_abnormal_hematopoietic_system | 0.94494033 |
69 | MP0008004_abnormal_stomach_pH | 0.88392471 |
70 | MP0002166_altered_tumor_susceptibility | 0.87192080 |
71 | MP0002933_joint_inflammation | 0.86311903 |
72 | MP0005390_skeleton_phenotype | 0.85097371 |
73 | MP0000920_abnormal_myelination | 0.84253554 |
74 | MP0001663_abnormal_digestive_system | 0.83573877 |
75 | MP0003806_abnormal_nucleotide_metabolis | 0.79357619 |
76 | MP0000249_abnormal_blood_vessel | 0.76805925 |
77 | MP0005167_abnormal_blood-brain_barrier | 0.76198115 |
78 | MP0003045_fibrosis | 0.74858160 |
79 | MP0003795_abnormal_bone_structure | 0.73058075 |
80 | MP0003329_amyloid_beta_deposits | 0.71686269 |
81 | MP0000569_abnormal_digit_pigmentation | 0.67383047 |
82 | MP0003656_abnormal_erythrocyte_physiolo | 0.66339333 |
83 | MP0001873_stomach_inflammation | 0.66154592 |
84 | MP0001986_abnormal_taste_sensitivity | 0.65444692 |
85 | MP0008874_decreased_physiological_sensi | 0.63762654 |
86 | MP0009765_abnormal_xenobiotic_induced | 0.62586192 |
87 | MP0006054_spinal_hemorrhage | 0.60887254 |
88 | MP0002138_abnormal_hepatobiliary_system | 0.59840491 |
89 | MP0000490_abnormal_crypts_of | 0.58425134 |
90 | MP0005388_respiratory_system_phenotype | 0.56963656 |
91 | MP0002133_abnormal_respiratory_system | 0.56963656 |
92 | MP0003091_abnormal_cell_migration | 0.56501422 |
93 | MP0001958_emphysema | 0.56040916 |
94 | MP0000015_abnormal_ear_pigmentation | 0.52169155 |
95 | MP0004808_abnormal_hematopoietic_stem | 0.51781714 |
96 | MP0005319_abnormal_enzyme/_coenzyme | 0.51326163 |
97 | MP0002332_abnormal_exercise_endurance | 0.49858897 |
98 | MP0002006_tumorigenesis | 0.48914377 |
99 | MP0005075_abnormal_melanosome_morpholog | 0.46914064 |
100 | MP0005381_digestive/alimentary_phenotyp | 0.46042621 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.72566418 |
2 | Recurrent abscess formation (HP:0002722) | 6.40507667 |
3 | Recurrent bacterial skin infections (HP:0005406) | 6.26307585 |
4 | Abnormality of macrophages (HP:0004311) | 5.79494089 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.46350705 |
6 | Myositis (HP:0100614) | 5.33771966 |
7 | Orchitis (HP:0100796) | 5.14636050 |
8 | Optic neuritis (HP:0100653) | 4.88794481 |
9 | Retrobulbar optic neuritis (HP:0100654) | 4.88794481 |
10 | Stomatitis (HP:0010280) | 4.25765216 |
11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.20152930 |
12 | Mediastinal lymphadenopathy (HP:0100721) | 4.16121887 |
13 | Recurrent skin infections (HP:0001581) | 4.03748692 |
14 | Recurrent fungal infections (HP:0002841) | 3.97363519 |
15 | Obstructive lung disease (HP:0006536) | 3.96573838 |
16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.96573838 |
17 | Gastrointestinal infarctions (HP:0005244) | 3.88981514 |
18 | Meningitis (HP:0001287) | 3.81509805 |
19 | Gingivitis (HP:0000230) | 3.80956861 |
20 | Spontaneous hematomas (HP:0007420) | 3.69180597 |
21 | Systemic lupus erythematosus (HP:0002725) | 3.63823250 |
22 | Keratoconjunctivitis sicca (HP:0001097) | 3.50733837 |
23 | Encephalitis (HP:0002383) | 3.48464165 |
24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.47308943 |
25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46428912 |
26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46428912 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.45272709 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.45272709 |
29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.45272709 |
30 | T lymphocytopenia (HP:0005403) | 3.39196731 |
31 | Abnormality of T cell number (HP:0011839) | 3.27634900 |
32 | Vasculitis (HP:0002633) | 3.25250493 |
33 | Keratoconjunctivitis (HP:0001096) | 3.21926727 |
34 | Urticaria (HP:0001025) | 3.21632795 |
35 | Hemoptysis (HP:0002105) | 3.07004219 |
36 | Pulmonary infiltrates (HP:0002113) | 3.05494484 |
37 | Increased IgE level (HP:0003212) | 2.95215584 |
38 | Cellulitis (HP:0100658) | 2.94351666 |
39 | Chronic otitis media (HP:0000389) | 2.89559923 |
40 | Chest pain (HP:0100749) | 2.89313423 |
41 | Leukocytosis (HP:0001974) | 2.85413158 |
42 | Increased cerebral lipofuscin (HP:0011813) | 2.85342918 |
43 | Prolonged bleeding time (HP:0003010) | 2.81986415 |
44 | Pustule (HP:0200039) | 2.79594033 |
45 | Gingival bleeding (HP:0000225) | 2.74378815 |
46 | Hypochromic microcytic anemia (HP:0004840) | 2.74351901 |
47 | Recurrent viral infections (HP:0004429) | 2.68846659 |
48 | Increased IgM level (HP:0003496) | 2.66673269 |
49 | Pulmonary embolism (HP:0002204) | 2.64506764 |
50 | Arterial thrombosis (HP:0004420) | 2.62528398 |
51 | Amyloidosis (HP:0011034) | 2.59443354 |
52 | Hypochromic anemia (HP:0001931) | 2.59113483 |
53 | Epistaxis (HP:0000421) | 2.58506131 |
54 | Purpura (HP:0000979) | 2.55775941 |
55 | Episodic fever (HP:0001954) | 2.53859104 |
56 | Anorexia (HP:0002039) | 2.52476509 |
57 | Peritonitis (HP:0002586) | 2.51405747 |
58 | Abnormality of T cells (HP:0002843) | 2.51020971 |
59 | Loss of speech (HP:0002371) | 2.44200659 |
60 | Nasal polyposis (HP:0100582) | 2.43412969 |
61 | Glomerulonephritis (HP:0000099) | 2.43072431 |
62 | Inflammation of the large intestine (HP:0002037) | 2.42524620 |
63 | Osteomyelitis (HP:0002754) | 2.40200747 |
64 | Recurrent bronchitis (HP:0002837) | 2.37977391 |
65 | Disinhibition (HP:0000734) | 2.37546397 |
66 | Abnormality of the nasal mucosa (HP:0000433) | 2.31199033 |
67 | Gastrointestinal inflammation (HP:0004386) | 2.31169864 |
68 | Granulocytopenia (HP:0001913) | 2.30921660 |
69 | Increased serum ferritin (HP:0003281) | 2.30442834 |
70 | Petechiae (HP:0000967) | 2.29884749 |
71 | Hypergammaglobulinemia (HP:0010702) | 2.29208900 |
72 | Premature loss of primary teeth (HP:0006323) | 2.26565541 |
73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26531513 |
74 | Gangrene (HP:0100758) | 2.24637268 |
75 | Abnormality of iron homeostasis (HP:0011031) | 2.19221349 |
76 | Dysostosis multiplex (HP:0000943) | 2.17178321 |
77 | Abnormality of the pleura (HP:0002103) | 2.17073384 |
78 | Autoimmune thrombocytopenia (HP:0001973) | 2.16270390 |
79 | Panhypogammaglobulinemia (HP:0003139) | 2.14581114 |
80 | Microcytic anemia (HP:0001935) | 2.13254504 |
81 | Eosinophilia (HP:0001880) | 2.09901877 |
82 | Sepsis (HP:0100806) | 2.09533217 |
83 | Glomerulopathy (HP:0100820) | 2.08203534 |
84 | Colitis (HP:0002583) | 2.05646027 |
85 | Abnormality of the endocardium (HP:0004306) | 2.03971485 |
86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02747997 |
87 | Abnormality of the peritoneum (HP:0002585) | 2.02716546 |
88 | Lymphopenia (HP:0001888) | 2.01128641 |
89 | Vertigo (HP:0002321) | 2.00842098 |
90 | Acne (HP:0001061) | 1.99557816 |
91 | Skin ulcer (HP:0200042) | 1.99233703 |
92 | Vacuolated lymphocytes (HP:0001922) | 1.96001931 |
93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94242728 |
94 | Hepatosplenomegaly (HP:0001433) | 1.93957370 |
95 | Polyneuropathy (HP:0001271) | 1.93890764 |
96 | Interstitial pulmonary disease (HP:0006530) | 1.90975763 |
97 | Malnutrition (HP:0004395) | 1.88510184 |
98 | Joint swelling (HP:0001386) | 1.86244858 |
99 | Recurrent pneumonia (HP:0006532) | 1.86085893 |
100 | Abnormality of T cell physiology (HP:0011840) | 1.82524864 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.63586890 |
2 | BLK | 3.86899289 |
3 | MAP4K1 | 3.60587782 |
4 | IRAK4 | 3.09401855 |
5 | TYK2 | 3.03651338 |
6 | CSK | 2.91986399 |
7 | FES | 2.66854375 |
8 | ERN1 | 2.62873710 |
9 | MAP2K3 | 2.60863429 |
10 | TXK | 2.31377208 |
11 | MAP3K13 | 2.25838926 |
12 | ZAP70 | 2.23654929 |
13 | TNK2 | 2.01519557 |
14 | FGR | 1.97756385 |
15 | JAK3 | 1.94295156 |
16 | EPHB1 | 1.91505801 |
17 | PRPF4B | 1.87727422 |
18 | MAP3K14 | 1.77968774 |
19 | GRK6 | 1.77309414 |
20 | SYK | 1.74123470 |
21 | HCK | 1.71124975 |
22 | BTK | 1.70701767 |
23 | MAP3K3 | 1.70170536 |
24 | TAOK3 | 1.69412429 |
25 | JAK1 | 1.57832901 |
26 | TGFBR2 | 1.57389245 |
27 | IKBKE | 1.57380889 |
28 | TAOK1 | 1.52669750 |
29 | CSF1R | 1.50803117 |
30 | LYN | 1.47598108 |
31 | MAP3K11 | 1.46006483 |
32 | JAK2 | 1.45232484 |
33 | TBK1 | 1.42743538 |
34 | KSR2 | 1.38206214 |
35 | KIT | 1.27962679 |
36 | LCK | 1.24571255 |
37 | MAP3K1 | 1.21817564 |
38 | BMPR2 | 1.15583709 |
39 | GRK7 | 1.11909174 |
40 | ITK | 1.10290984 |
41 | MATK | 1.10264614 |
42 | YES1 | 1.05746605 |
43 | MARK3 | 0.96859441 |
44 | SIK3 | 0.93642330 |
45 | STK10 | 0.92343413 |
46 | PDK1 | 0.91382452 |
47 | IKBKB | 0.91046001 |
48 | MARK2 | 0.84310792 |
49 | IRAK1 | 0.84231710 |
50 | PDPK1 | 0.81121951 |
51 | TEC | 0.80433465 |
52 | PTK6 | 0.77931849 |
53 | PRKD2 | 0.73560401 |
54 | FYN | 0.72868170 |
55 | MOS | 0.70740715 |
56 | TAOK2 | 0.70510707 |
57 | FGFR4 | 0.69934168 |
58 | CDC42BPA | 0.69683122 |
59 | IRAK2 | 0.69640972 |
60 | LRRK2 | 0.68364142 |
61 | TESK2 | 0.67305569 |
62 | MAP3K6 | 0.65878084 |
63 | MAP3K2 | 0.65309534 |
64 | EPHA3 | 0.64151551 |
65 | KSR1 | 0.63641403 |
66 | PIK3CG | 0.60934464 |
67 | FGFR3 | 0.60827932 |
68 | MAPK12 | 0.60486273 |
69 | TRIB3 | 0.56914223 |
70 | MAP3K7 | 0.55176957 |
71 | PRKCQ | 0.54253752 |
72 | CAMKK2 | 0.53846130 |
73 | RIPK1 | 0.53480605 |
74 | SGK3 | 0.49927520 |
75 | MAPK7 | 0.49778870 |
76 | SIK2 | 0.49660969 |
77 | RAF1 | 0.49015490 |
78 | MAP3K5 | 0.48755323 |
79 | DYRK1B | 0.48684284 |
80 | MAP2K4 | 0.46417566 |
81 | MAP2K6 | 0.45110800 |
82 | PTK2B | 0.44781969 |
83 | STK11 | 0.44515806 |
84 | HIPK2 | 0.44068835 |
85 | RET | 0.43890959 |
86 | CDK19 | 0.42450299 |
87 | PIM1 | 0.39974071 |
88 | ACVR1B | 0.39060085 |
89 | RPS6KL1 | 0.37661618 |
90 | RPS6KC1 | 0.37661618 |
91 | SGK2 | 0.36852952 |
92 | DAPK2 | 0.35694464 |
93 | IRAK3 | 0.35625107 |
94 | NLK | 0.34353071 |
95 | MAPKAPK2 | 0.34291591 |
96 | CAMKK1 | 0.32995062 |
97 | STK38 | 0.31744482 |
98 | PRKCH | 0.31724656 |
99 | RPS6KA6 | 0.30446951 |
100 | PRKCD | 0.29889674 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.46164512 |
2 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.00169629 |
3 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.91697871 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.84680299 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 2.76081022 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.58071819 |
7 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.28398912 |
8 | * Tuberculosis_Homo sapiens_hsa05152 | 2.16535432 |
9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.13581563 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12290207 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.08797813 |
12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99864701 |
13 | Malaria_Homo sapiens_hsa05144 | 1.95838219 |
14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95612366 |
15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87564519 |
16 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87506444 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80970813 |
18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.78357958 |
19 | * Phagosome_Homo sapiens_hsa04145 | 1.69575156 |
20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.69297297 |
21 | Measles_Homo sapiens_hsa05162 | 1.65818522 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65735892 |
23 | Asthma_Homo sapiens_hsa05310 | 1.63044209 |
24 | Legionellosis_Homo sapiens_hsa05134 | 1.59465240 |
25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56986615 |
26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56975382 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52980921 |
28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52815456 |
29 | Pertussis_Homo sapiens_hsa05133 | 1.52311424 |
30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50667508 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50584333 |
32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48373207 |
33 | Influenza A_Homo sapiens_hsa05164 | 1.47169134 |
34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46538408 |
35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46173028 |
36 | Lysosome_Homo sapiens_hsa04142 | 1.34576578 |
37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33272153 |
38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25963671 |
39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21441725 |
40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21310678 |
41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17731613 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15124251 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12729398 |
44 | Salmonella infection_Homo sapiens_hsa05132 | 1.08747943 |
45 | Platelet activation_Homo sapiens_hsa04611 | 1.04576579 |
46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00560205 |
47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00498225 |
48 | Hepatitis C_Homo sapiens_hsa05160 | 0.99890386 |
49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96729454 |
50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95649364 |
51 | Hepatitis B_Homo sapiens_hsa05161 | 0.93748964 |
52 | Apoptosis_Homo sapiens_hsa04210 | 0.89548507 |
53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88588647 |
54 | Shigellosis_Homo sapiens_hsa05131 | 0.85532206 |
55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81616038 |
56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80694810 |
57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.77904454 |
58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77394283 |
59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75401854 |
60 | Endocytosis_Homo sapiens_hsa04144 | 0.72405445 |
61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70191397 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68670621 |
63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65729771 |
64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65413996 |
65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64667637 |
66 | Amoebiasis_Homo sapiens_hsa05146 | 0.63365542 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63166555 |
68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62946835 |
69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61198173 |
70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59075285 |
71 | Prion diseases_Homo sapiens_hsa05020 | 0.54270233 |
72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52901087 |
73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52296361 |
74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51417404 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51294188 |
76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48785071 |
77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45333725 |
78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44836493 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44671132 |
80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44564996 |
81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43431650 |
82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41714322 |
83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40955750 |
84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40761167 |
85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40588373 |
86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40576789 |
87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39529379 |
88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38102074 |
89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36579444 |
90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36290907 |
91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35144702 |
92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34827133 |
93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31359656 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.31232325 |
95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30329969 |
96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30300811 |
97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29968288 |
98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29886718 |
99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29196492 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28638696 |